This NDC is on FDA's drug shortage list (posted Mar 23, 2018)
Reported reason: Demand increase for the drug
Product Information
KETOROLAC 60 MG/2 ML VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $0.5524 per ML under NDC 25021070102. Its NADAC has been published 524 times since Feb 10, 2016.
FDA first approved this application on Nov 1, 2016. Its Orange Book therapeutic-equivalence code is AP.
Strength
30 mg/mL
Manufacturer
Sagent PharmaceuticalsNDC
25021070102
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA204216FDA Approved
11/1/2016
TE Code
AP
On Market Since
9/5/2014
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 60 MG/2 ML VIAL has been published 524 times since Feb 10, 2016, and over the history we have for it it has declined 43.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5524 per ML |
|---|---|
| All-time high | $1.3672 (Oct 12, 2016) |
| All-time low | $0.4543 (Feb 18, 2026) |
| 52-week high | $0.5738 |
| 52-week low | $0.4543 |
| Median price | $0.8975 |
| Average price | $0.9228 |
| Largest weekly change | +26.5% (Mar 23, 2016) |
| Weeks tracked | 524 |
| Tracking since | Feb 10, 2016 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ketorolac tromethamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cyclooxygenase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOROLAC 60 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 60 MG/2 ML VIAL, manufactured by Sagent Pharmaceuticals, is $0.5524 per ML (NDC 25021070102), effective Sep 30, 2026.
How has the price of KETOROLAC 60 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 60 MG/2 ML VIAL has declined 43.6%. It has been tracked across 524 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for KETOROLAC 60 MG/2 ML VIAL?
Since Feb 10, 2016, the NADAC for KETOROLAC 60 MG/2 ML VIAL has ranged from a low of $0.4543 (Feb 18, 2026) to a high of $1.3672 (Oct 12, 2016), with a median of $0.8975 per ML.
Are there cheaper alternatives to KETOROLAC 60 MG/2 ML VIAL?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETOROLAC 60 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures KETOROLAC 60 MG/2 ML VIAL?
KETOROLAC 60 MG/2 ML VIAL (NDC 25021070102) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.
Is KETOROLAC 60 MG/2 ML VIAL in shortage?
Yes — NDC 25021070102 is currently listed in FDA's drug shortage database (posted Mar 23, 2018). Reported reason: Demand increase for the drug.